Status | Study |
Recruiting |
Study Name: Autologous Stem Cell Transplant Followed By Maintenance Therapy in Treating Elderly Patients With Multiple Myeloma Condition: Extramedullary Plasmacytoma Isolated Plasmacytoma of Bone Date: 2013-05-06 Interventions: Drug: dexamethasone Given PO |
Suspended |
Study Name: First-line Pomalidomide, Bortezomib, and Dexamethasone For AL Amyloidosis or LCDD Condition: Light Chain Deposition Disease Primary Systemic Amyloidosis Date: 2012-11-13 Interventions: Drug: pomalidomide Given PO |
Completed |
Study Name: Viral Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma Condition: Light Chain Deposition Disease Refractory Plasma Cell Myeloma Date: 2012-02-11 Interventions: Other: Diagnostic Laboratory Biomarker Analysis |
Active, not recruiting |
Study Name: Bortezomib/Dexamethasone (BD), Followed By Autologous Stem Cell Transplantation and Maintenance Bortezomib/Dexamethasone For the Initial Treatment of Monoclonal Immunoglobulin Deposition Disease (MIDD) Associated With Multiple Myeloma and AL Amyloidosis Condition: Light Chain Deposition Disease (LCDD or MIDD) Light Chain and H Date: 2011-06-27 Interventions: Drug: Bortezomib/Dexamethasone (BD), Followed By Autologous STC & Maintenance Bortezomib/Dexamethasone |
Recruiting |
Study Name: Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma Condition: Light Chain Deposition Disease Smoldering Plasma Cell Myeloma Date: 2010-07-23 Interventions: Other: Clinical Observation Un |
Completed |
Study Name: Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis Condition: Light Chain Deposition Disease Primary Systemic Amyloidosis Date: 2010-02-27 Interventions: Drug: melphalan Given PO |
Active, not recruiting |
Study Name: Detecting Early Myocardial Infiltration w/Amyloid & Light Chain Deposition Disease in Multiple Myeloma Subjects Condition: Multiple Myeloma Date: 2009-11-16 Interventions: Device: Administering three additional MRI images Three additional MRI images to determine the role of c |
Completed |
Study Name: Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy Condition: Accelerated Phase Chronic Myelogenous Leukemia Acute Myeloid Leukemia With Multilineage Dysp Date: 2009-04-29 Interventions: Drug: sunitinib malate Given P |
Terminated |
Study Name: HD Melphalan and SCT in Patients With IGDD or LCDD Condition: Multiple Myeloma Date: 2008-05-18 Interventions: Biological: filgrastim 16 mcg/ |
Active, not recruiting |
Study Name: Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease Condition: Primary Systemic Amyloidosis Light Chain Deposition Disease Date: 2007-08-24 Interventions: Drug: bortezomib Bortezomib 1. |